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Abstract: Two Burkholderia gladioli strains isolated from the
lungs of cystic fibrosis patients were found to produce unusual
lipodepsipeptides containing a unique citrate-derived fatty acid
and a rare dehydro-b-alanine residue. The gene cluster res-
ponsible for their biosynthesis was identified by bioinformatics
and insertional mutagenesis. In-frame deletions and enzyme
activity assays were used to investigate the functions of several
proteins encoded by the biosynthetic gene cluster, which was
found in the genomes of about 45% of B. gladioli isolates,
suggesting that its metabolic products play an important role in
the growth and/or survival of the species. The Chrome Azu-
rol S assay indicated that these metabolites bind ferric iron,
which suppresses their production when added to the growth
medium. Moreover, a gene encoding a TonB-dependent ferric-
siderophore receptor is adjacent to the biosynthetic genes,
suggesting that these metabolites may function as siderophores
in B. gladioli.
Introduction
Iron is an essential element for most organisms. In bio-
logical systems, iron is mainly present in two oxidation states:
ferrous and ferric.[1] The interconversion of the ferrous and
ferric oxidation states is essential for a variety of redox
reactions and electron transfer processes in cells.[2] However,
despite the relatively high abundance of iron in the Earths
crust, it is not readily bioavailable. This is because it is pre-
dominantly in the ferric form, which has low aqueous solu-
bility.[3] Moreover, sequestration by proteins such as hemo-
globin, ferritin, transferrin, and lactoferrin also contributes to
low iron availability in mammals.[3] As a consequence, mi-
croorganisms have evolved several strategies for obtaining
iron from the environment and their hosts. One strategy in-
volves the production of siderophores, specialised metabolites
with a high affinity for ferric iron.[4] In Gram-negative bac-
teria, ferric-siderophore complexes are typically transported
into the periplasm by TonB-dependent outer membrane re-
ceptors. Periplasmic binding proteins then shuttle the ferric-
siderophore complexes to the inner membrane, where ATP-
binding cassette (ABC) transporters transfer them into the
cytoplasm.[5] Once in the cytoplasm, iron is released from the
ferric-siderophore complex by reduction to the ferrous form
and/or hydrolytic cleavage of the ligand.[5a]
Several investigations of pathogenic microorganisms have
identified a strong link between siderophore production and
virulence.[6] In the early stages of infection, siderophores play
a key role in sequestering iron from host tissues. The iden-
tification of siderophores produced by pathogenic mi-
croorganisms is therefore an important field of study because
interference with siderophore-mediated iron uptake is an
attractive strategy for attenuating virulence.[7] The discovery
of novel siderophores is also relevant to other therapeutic
applications. For example, desferrioxamine B (marketed as
Desferal), a siderophore produced by numerous Streptomyces
species,[8] is used to treat iron overload resulting from multiple
blood transfusions and aluminium toxicity due to dialysis.
However, because Desferal is administered by injection and
has multiple side effects, orally available alternatives with
fewer side effects are actively being sought.[9] In addition to
clinical uses, siderophores show promise for environmental
and biotechnological applications.[10]
Burkholderia is a genus of highly diverse Gram-negative
bacteria. Species belonging to this genus have been isolated
from soil, water, plants, animals and humans.[11] Several in-
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vestigations have shown that they are prolific producers of
specialised metabolites,[12] and genome sequence analyses
have highlighted their underexplored biosynthetic poten-
tial.[13] To date, pathogenic Burkholderia species have been
reported to produce siderophores belonging to four distinct
structural classes (ornibactins/malleobactins, pyochelin, ce-
pabactin, and cepaciachelin; Figure 1).[14] Members of the
cepacia complex and pseudomallei group produce one or
more of these siderophores. In contrast, Burkholderia gladioli
does not produce any of these metabolites and was long be-
lieved to employ siderophore-independent mechanisms for
iron acquisition.[15] However, Hertweck and co-workers re-
cently reported that three B. gladioli environmental isolates
produce the diazeniumdiolate siderophore gladiobactin.[16]
We have recently discovered that B. gladioli BCC0238,
isolated from the sputum of a child with cystic fibrosis (CF),
produces several specialised metabolites. These include gla-
diolin, a novel macrolide with potent activity against drug
resistant Mycobacterium tuberculosis clinical isolates,[12i] and
icosalide A1,[17] an asymmetric lipopeptodiolide antibiotic
originally isolated from an Aureobasidium species fungus,[18]
but subsequently shown to be produced by various strains of
B. gladioli including one associated with the fungus.[17,19]
Analysis of the B. gladioli BCC0238 complete genome se-
quence identified several gene clusters encoding cryptic
nonribosomal peptide synthetase (NRPS), polyketide syn-
thase (PKS) and hybrid NRPS-PKS assembly lines.[12g] Here
we report the discovery of bolagladins A and B, novel lipo-
depsipeptides containing a unique citrate-derived fatty acid
and a rare dehydro-b-alanine residue, as the metabolic pro-
ducts of one of these gene clusters. A combination of com-
parative bioinformatics analyses, targeted gene deletions, and
enzyme activity assays elucidated several key steps in the
biosynthesis of these unusual natural products, which we
propose based on several lines of evidence may function as
siderophores.
Results and Discussion
Isolation and Structure Elucidation of the Bolagladins
B. gladioli BCC0238 produces gladiolin and icosalide A1
when grown on a solid minimal medium containing glycerol
as the sole carbon source.[12i, 17] Two novel metabolites were
identified by UHPLC-ESI-Q-TOF-MS analysis of extracts
from cultures of a gladiolin nonproducing mutant of B. gla-
dioli BCC0238 (with an in-frame deletion in the region of
gbnD1 encoding the ER domain) grown on BSM medium
containing ribose as an additional carbon source alongside
glycerol. The metabolites were isolated as amorphous solids
from ethyl acetate extracts of 3 day cultures (1 L total vo-
lume) using semipreparative HPLC, and their planar struc-
tures were elucidated using a combination of HR-ESI-MS
and 1D/2D NMR experiments (Figure 2; Tables S2 and S3,
Figures S1–S14).
The molecular formulae of the two metabolites, which we
named bolagladins A 1 and B 2, due to their bolaamphiphilic
nature, were established as C39H61N5O14 (calculated for
C39H62N5O14
+: 824.4288, found: 824.4284) and C40H63N5O14
(calculated for C40H64N5O14
+: 838.4444, found: 838.4447),
respectively, using positive ion ESI-Q-TOF MS (Figure S17).
Four resonances with chemical shifts characteristic of protons
attached to C2 in a-amino acids (dH 4.17, 4.79, 5.36, and 5.52)
correlated with signals attributable to exchangeable NH
protons (dH 8.17, 8.70, 9.91, and 9.99, respectively) in the
COSY spectrum of bolagladin A 1. Further analysis of
1H NMR and COSY spectra identified four a-amino acid spin
systems, which in conjunction with HSQC and HMBC data,
Figure 1. Structure of ornibactins, malleobactin E, pyochelin, cepacia-
chelin, and cepabactin identified from pathogenic strains of Burkholde-
ria.
Figure 2. Structures of bolagladin A (1) and B (2). COSY and key
HMBC correlations are shown for bolagladin A.
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were assigned to a valine residue, a homoserine (Hse) residue
and two serine residues in the sequence Ser-Hse-Val-Ser
(Figure 2). A 3JCH correlation from the b-protons of the N-
terminal Ser (N-Ser) residue (dH 4.73 and 4.90) to the car-
bonyl carbon of the C-terminal Ser (C-Ser) residue (dC 170.0)
established the presence of a tetradepsipeptide (Figure 2).
Analysis of the COSY and HMBC data also revealed a de-
hydro-b-alanine (Dba) residue, with a coupling constant of
14.0 Hz between the a and b protons indicating that the
double bond is E-configured. The only other natural products
reported to contain a Dba residue are the enamidonins iso-
lated from Streptomyces species.[20] 2JCH correlations were
observed between the NH proton of the N-Ser residue in the
tetradepsipeptide (dH 9.99) and the carbonyl carbon of the
Dba residue (dC 168.3), and the NH proton of Dba residue
(dH 11.56) and the carbonyl carbon of a fatty acid residue (dC
165.1). This indicates that the Dba residue links the fatty acid
residue to the tetradepsipeptide. The fatty acid residue is very
unusual, with Z-configured double bonds spanning C2–C3
and C11–C12 (based on CH=CH coupling constants of 11.5
and 13.5 Hz, respectively), and two carboxylic acid groups
and a methoxy group appended to its tail (Figure 2).
The absolute configurations of the a-amino acid residues
in bolagladin A 1 were determined as l-Ser-d-Val-l-Hse-l-
Ser using Marfeys method[21] (Figure S15). Comparison of
the NMR spectroscopic data for bolagladins A 1 and B 2
showed that the Val residue in the former is substituted by an
Ile residue in the latter, consistent with the difference of CH2
in the molecular formulae. The absolute configurations of the
a-amino acids in bolagladin B (2) were similarly shown to be
l-Ser-d-allo-Ile-l-Hse-l-Ser by Marfeys method (Fig-
ure S15), using a C3 column instead of a C18 column to se-
parate the Marfeys derivatives of d-Ile and d-allo-Ile (Fig-
ure S15).[22]
Overall, the structures of bolagladins A 1 and B 2 are
highly unusual, containing a unique fatty acid residue with
several polar functional groups appended to its tail, linked via
a rare Dba residue to a depsitetrapeptide. We thus sought to
develop an understanding of bolagladin biosynthesis, focusing
on the origin of the starter unit for the fatty acid assembly and
the mechanism of Dba incorporation.
Bolagladin Biosynthesis
Bioinformatics analysis of the B. gladioli BCC0238 geno-
me sequence identified the putative bolagladin (bol) biosyn-
thetic gene cluster (Figure 3 and Table S4), which contains
a gene (bolH) encoding a tetramodular NRPS. Sequence
analysis of the adenylation (A) domains in this NRPS in-
dicated that modules 1–4 activate l-Ser, l-Val/l-Ile, l-Hse
and l-Ser, respectively (Table S5),[23] suggesting the NRPS
assembles the depsipeptide portion of the bolagladins. Simi-
larly, phylogenetic analysis of the BolH condensation (C)
domains indicated that they belong to the following groups.[24]
Module 1: chain initiating (CI—links external acyl donor and
l-configured acyl acceptor); modules 2 and 4: chain elonga-
ting (LCL—links l-configured acyl donor and acceptor); and
module 3: bifunctional condensation/epimerization (CE—
epimerizes acyl donor to d-configuration and links with l-
configured acyl acceptor; Figure 3). This is consistent with the
structure elucidation data, which indicate that the bolagladins
contain l-Ser, l-Hse and d-Val/d-allo-Ile.
To verify the involvement of this gene cluster in bola-
gladin biosynthesis, we inactivated bolH in B. gladioli
BCC0238 DgbnD1_ER via insertional mutagenesis. LC–MS
analysis confirmed that the production of bolagladins A 1 and
B 2 was abolished in the mutant (Figure 4).
Putative functions were assigned to the proteins encoded
by the bolA-bolT genes flanking bolH on the basis of se-
quence analyses (Table S4). This enabled us to propose
a plausible pathway for bolagladin biosynthesis (Figure 3). To
validate this pathway experimentally, we envisioned exami-
ning the effect of in-frame deletions in key biosynthetic genes
on bolagladin production. However, this proved to be chal-
lenging and time consuming in B. gladioli BCC0238 (see
Supporting Information), so we screened other genome-se-
quenced B. gladioli isolates containing the bol locus (see be-
low) to establish whether they i) produce the bolagladins and
ii) are amenable to construction of in-frame deletions.
B. gladioli BCC1622 (also isolated from a CF lung infection)
was found to meet both criteria and an analogous gladiolin
nonproducing mutant of this strain (B. gladioli BCC1622
DgbnD1_ER) was created to enable in-depth functional stu-
dies of selected bolagladin biosynthetic genes. BolR shows
sequence similarity to citrate synthase, a key enzyme in the
Krebs cycle, which catalyzes the condensation of acetyl-CoA
with oxaloactetate and hydrolysis of the resulting thioester to
form citrate (Figure 5a).[25] This suggests that citryl-CoA may
serve as the starter unit for assembly of the unusual fatty acid
residue incorporated into the bolagladins (Figure 3). To verify
the function of BolR, we overproduced it in E. coli as an N-
terminal His6-fusion and purified it to homogeneity (see
Supporting Information). Incubation of the purified protein
with oxaloacetate (4) and acetyl-CoA (5) for 2 h at room
temperature resulted in complete conversion to products with
molecular formulae corresponding to citric acid (6) and
coenzyme A 7 (Figure 5b).
To probe the role played by citrate in bolagladin biosyn-
thesis, we constructed an in-frame deletion in bolR. The res-
ulting mutant was unable to assemble bolagladins A and B,
but produced a new metabolite with the molecular formula
C37H59N5O12 (calculated for C37H60N5O12
+: 766.4233, found:
766.4238; Figures 6 and S16). The production level of this
metabolite was insufficient for NMR spectroscopic analysis.
We therefore conducted LC–MS/MS analyses, which in-
dicated the metabolite has the same depsipeptide core as
bolagladin B 2 (molecular formula C40H63N5O14; Figures 6
and S16) and that the structural differences must lie in the
fatty acid and/or Dba residues. However, because the new
metabolite contains three fewer carbon atoms, four fewer
hydrogen atoms and two fewer oxygen atoms than bola-
gladin B, but the same number of nitrogen atoms, these dif-
ferences cannot be due to modification or loss of the Dba
residue. The most plausible structure for this metabolite is 3,
in which the fatty acid residue is derived from an oxaloacetyl-
CoA starter unit that is subsequently reduced (Figure 6). This
suggests that BolR may catalyze the condensation of acetyl-
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CoA with the keto group of oxaloacetyl-CoA in bolagadin
biosynthesis (Figure S17), but further experiments will be
required to confirm this.
We postulated that BolS, which shows sequence similarity
to S-adenosyl-l-methione (SAM) dependent methyltrans-
ferases, catalyzes methylation of the hydroxyl group in the
citrate-derived starter unit at some point during bolagladin
biosynthesis. To test this hypothesis, we constructed an in-
frame deletion in bolS. The production of bolagladins A 1 and
B 2 was abrogated in the resulting mutant and two new me-
tabolites with the molecular formulae C38H59N5O14 (calcula-
ted for C38H60N5O14
+: 810.4131, found: 810.4124) and
C39H61N5O14 (calculated for C39H62N5O14
+: 824.4288, found:
824.4296) were produced (Figures 7 and S16). LC–MS/MS
analyses indicated that these compounds are congeners of
1 and 2, lacking a CH2 group from the fatty acid or Dba
residues (Figure S17). Although production levels of these
metabolites were low, we were able to purify a sufficient
quantity of the bolagladin B congener for NMR spectroscopic
analysis (Table S6, Figures S18–S23). Differences were ob-
Figure 3. Organization of the bolagladin biosynthetic gene cluster (bolA-T) and proposed pathway for bolagladin biosynthesis. The precise timing
of O-methylation of the citrate-derived starter unit for fatty acid biosynthesis remains to be established, but it is postulated to be an early step.
Abbreviations are as follows: A, adenylation domain; TE, thioesterase domain; CI, chain initiating condensation domain;
LCL, chain elongating
condensation domain utilizing two l-configured aminoacyl thioesters; CE, bifunctional epimerization–condensation domain; FAS, fatty acid syn-
thase. Acyl carrier proteins (ACPs) and peptidyl carrier protein (PCP) domains are shown as black circles.
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served in the 13C chemical shifts of the resonances due to C16,
C17, C18, C19 and C20 in the fatty acid residue and the signals
attributed to the O-methyl group in bolagladin B were absent
from the 1H and 13C spectra. We therefore conclude that the
two metabolites accumulated in the bolS mutant are des-
methyl-bolagladins A 8 and B 9. The low levels of 8 and 9
produced by the mutant suggest O-methylation of the citrate-
derived starter unit is an early step in bolagladin biosynthesis,
rather than a late-stage modification. However, the precise
timing of this reaction remains to be determined.
Citrate (or its O-methylated derivative) is proposed to be
converted to the corresponding coenzyme A thioester by
BolB, which shows similarity to acyl-CoA synthetases (Fig-
ure 3 and Table S4). Either BolM or BolP, both of which show
similarity to b-ketoacyl synthase III (KAS III) enzymes that
typically initiate fatty acid biosynthesis in bacteria (Tab-
le S4),[26] could then catalyse the elongation of citryl-CoA (or
its O-methylated derivative) with a malonyl group attached to
the primary metabolic fatty acid synthase (FAS) acyl carrier
protein (ACP) (Figure 3). Interestingly, the conserved active
site Cys residue is mutated to Ser in BolM and Thr in BolP.
The functional significance of this is unclear, but an analogous
Cys to Ser mutation is observed in DpsC, a KASIII homo-
logue that has been reported to initiate assembly of the
daunorubicin polyketide chain using a propionyl-CoA starter
unit.[27] Further processing of the b-ketothioester resulting
from elongation of (O-methyl)-citryl-CoA with malonyl-ACP
Figure 4. Comparison of the extracted ion chromatograms for
m/z 824.4288 (1) and 838.4444 (2) from UHPLC-ESI-Q-TOF MS analy-
ses of culture extracts from B. gladioli BCC0238 DgbnD1_ER (black)
and B. gladioli BCC0238 DgbnD1_ER-WbolH (red). Insertional muta-
genesis in bolH confirmed the involvement of the bol cluster in bola-
gladin production.
Figure 6. a) Comparison of fragment ions observed for metabolite 3
and bolagladin B (2) in MS/MS analyses. b) Extracted ion chromato-
grams (EICs) from UHPLC-ESI-Q-TOF MS analyses of extracts from
B. gladioli BCC1622 DgbnD1_ER and a bolR deletion mutant. From top
to bottom, these are: EIC at m/z 824.4288 (corresponding to [M+H]+
for 1) and 838.4444 (corresponding to [M+H]+ for 2) for the wild-type
strain; EIC at m/z 824.4288 and 838.4444 for the mutant; EIC at
m/z 766.4233 (corresponding to [M+H]+ for 3) for the wild-type strain;
and EIC at m/z 766.4233 for the mutant.
Figure 5. a) Reaction catalyzed by BolR. b) Extracted ion chromato-
grams for m/z 130.9986, 808.1185, 191.0197, and 766.1079 corres-
ponding to [MH] for 4, 5, 6, and 7 from negative ion mode UHPLC-
ESI-Q-TOF MS analyses of the BolR-catalyzed condensation of oxaloa-
cetate with acetyl-CoA (top) and a negative control reaction containing
BolR inactivated by boiling for 15 min prior to addition (bottom). The
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by the primary metabolic FAS would afford the saturated O-
methyl-citrate-primed fatty acyl-ACP thioester 10 (Figure 3).
The 11, 12 and 2, 3 double bonds are likely introduced into
this thioester by BolF and BolL, which are similar to mem-
brane-associated fatty acid desaturases and acyl-ACP des-
aturases, respectively (Figure 3 and Table S4), completing the
assembly of the unusual fatty acid residue incorporated into
the bolagladins.
The Dba residue of the bolagladins is postulated to derive
from l-aspartate, which we propose undergoes adenylation of
its b-carboxyl group catalyzed by BolO, followed by transfer
onto BolC, a putative freestanding ACP (Figure 3). BolO
shows similarity to VinN,[28] which catalyzes adenylation of
the b-carboxyl group of b-methyl-aspartate and subsequent
transfer to the freestanding ACP VinL in the biosynthesis of
vicenistatin. Moreover, the Asp230 and Ser299/Arg331 res-
idues in VinN, which are proposed to play a key role in re-
cognition of the a-amino and a-carboxyl groups of b-methyl-
aspartate, respectively, are conserved in BolO (Figure S24).
In vicenistatin biosynthesis, the pyridoxal phosphate (PLP)-
dependent enzyme VinO catalyses decarboxylation of the b-
methyl-isoaspartyl-VinL thioester to form the corresponding
a-methyl-b-alanyl thioester.[24] We propose that BolN, which
shows sequence similarity to BtrK, a PLP-dependent enzyme
that catalyzes decarboxylation of an iso-glutamyl-ACP
thioester in butirosin biosynthesis, plays an analogous role in
bolagladin biosynthesis (Figure 3). In-frame deletion of bolN
abolished bolagladin production and it could not be restored
by feeding b-alanine to the mutant. This is consistent with the
proposed roles of BolO, BolC and BolN and rules out b-
alanine as an intermediate in the biosynthetic pathway. The
amino group of the b-alanyl-BolC thioester is proposed to be
condensed with the citrate-primed fatty acyl thioester by one
of the KAS III homologues BolM or BolP (Figure 3).
The sequence similarity of BolQ to acyl-CoA dehydro-
genases suggested it might be responsible for formation of the
Dba residue via desaturation of the N-acyl-b-alanyl-BolC
thioester. To test this hypothesis, we created an in-frame
deletion in bolQ, which abolished the production of bola-
gladins A and B and led to the accumulation of two new
metabolites with the molecular formulae C39H63N5O14 and
C40H65N5O14 (Figure 8). Purification and NMR spectroscopic
analysis showed these metabolites are dihydro-bolagladins A
11 and B 12, in which the Dba residue has been replaced by b-
alanine (Tables S7 and S8, and Figures S25–S35). This is
consistent with the proposed function of BolQ as a N-acyl-b-
alanyl thioester desaturase, although on the basis of these
data the possibility of BolQ converting the b-alanine residue
to Dba at a later stage in bolagladin biosynthesis cannot be
ruled out.
The bol Locus is Widely Conserved in B. gladioli
A local nucleotide BLAST search of 1318 genomes re-
presenting Burkholderia, Paraburkholderia and Caballeronia
species showed B. gladioli is the only species containing the
bolagladin biosynthetic gene cluster (as indicated by the
presence of bolH).[29] Read mapping of paired-end Illumina
reads from 234 B. gladioli strains against the bol gene cluster
revealed that it is present in 105 strains. However, there is
evidence of gene substitutions and deletions in the regions
Figure 7. a) Structures of desmethyl-bolagladins A 8 and B 9 accumu-
lated in the bolS mutant of B. gladioli BCC1622 DgbnD1_ER. b) Top:
Extracted ion chromatogram at m/z 824.4288 (corresponding to
[M+H]+ for 1) and 838.4444 (corresponding to [M+H]+ for 2) from
UHPLC-ESI-Q-TOF MS analyses of culture extracts from B. gladioli
BCC1622 DgbnD1_ER. Bottom: Extracted ion chromatogram at
m/z 810.4131 (corresponding to [M+H]+ for 8) and 824.4288 (corres-
ponding to [M+H]+ for 9) from UHPLC-ESI-Q-TOF MS analyses of cul-
ture extracts from the bolS mutant of B. gladioli BCC1622 DgbnD1_ER.
Figure 8. a) Structures of dihydro-bolagladins A (11) and B (12) pro-
duced by the bolQ mutant of B. gladioli BCC1622 DgbnD1_ER. b) Ex-
tracted ion chromatograms at m/z 824.4288 and 838.4444 (in blue;
corresponding to [M+H]+ for bolagladins A (1) and B (2), respectiv-
ely), and 826.4444 and 840.4601 (in red, corresponding to [M+H]+ for
dihydro-bolagladins A (11) and B (12), respectively) from UHPLC-ESI-
Q-TOF MS analyses of culture extracts from B. gladioli BCC1622
DgbnD1_ER and the bolQ mutant.
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flanking the cluster (Figure 9). The bolU gene, encoding
a putative TonB-dependent ferric-siderophore outer mem-
brane receptor, is absent from five of the 105 B. gladioli
genomes (BCC1837, BCC1843, BCC1861, BCC1870 and
BCC1871) containing the bolagladin biosynthetic gene cluster
and is present in 52% (67 of 129) of genomes lacking it.
Biological Function of the Bolagladins
Bolagladins A (1) and B (2) showed no activity at a con-
centration of 64 mgmL1 in disc diffusion assays against any of
the ESKAPE panel of bacterial pathogens,[30] Mycobacterium
bovis BCG, or Candida albicans. The 3-methoxy-1,4-di-
carboxylate moiety of the bolagladins is reminiscent of ferric-
iron-chelating citrate residues in several siderophores, such as
achromobactin, vibrioferrin, and staphyloferrin B.[31] Mo-
reover, bolU flanking the left end of the bolagladin biosyn-
thetic gene cluster encodes a putative TonB-dependent ferric-
siderophore outer membrane receptor. We thus hypothesised
that the bolagladins could function as siderophores. Although
ferric complexes of the bolagladins were too labile to observe
in ESI-Q-TOF MS analyses, the chrome azurol S (CAS) assay
indicated they are able to sequester ferric iron, albeit at hig-
her concentrations than typical trishydroxamate siderophores
(Figure S36).[4]
Siderophore production in microbes is usually regulated
by iron availability. In iron-deficient media, production is
upregulated, whereas in iron replete media it is suppressed.
Accordingly, the level of bolagladin production by B. gladioli
BCC1622 DgbnD1_ER decreased as increasing concentra-
tions of ferric iron were added to the medium (Figure S36).
Combined with the results of the CAS assay, these data in-
dicate that the bolagladins may function as siderophores in
B. gladioli.
Siderophores often contribute to virulence in pathogenic
bacteria. Thus, we used a Galleria mellonella wax moth in-
fection model to investigate whether the bolagladins are
a virulence factor in B. gladioli. Ornibactin was shown to
contribute to virulence in Burkholderia cenocepacia using this
and other models.[15, 32] However, no attenuation of virulence
towards the wax moth larvae was observed in the DbolN
mutant of B. gladioli BCC1622 DgbnD1_ER, relative to the
parental strain (Figure S37).
A similar observation was reported for pyochelin defi-
cient mutants of B. cenocepacia H111,[32] leading to the hy-
pothesis that some Burkholderia siderophores may play a role
in metal homeostasis rather than virulence.[33] To investigate
this hypothesis, B. cenocepacia H111 pyochelin and orni-
bactin nonproducing mutants were grown alongside the wild-
type strain in media containing various metal salts (10–
50 mM). The metal salts did not affect the wild-type strain, but
were toxic to the siderophore nonproducing mutants, in-
dicating that pyochelin and ornibactin protect B. cenocepacia
against metal ion toxicity.[33] This finding was further sup-
ported by supplementing the medium with pyochelin and
ornibactin, which reversed toxicity in the siderophore non-
producing mutants.[33]
We thus compared the tolerance of the B. gladioli
BCC1622 DgbnD1_ER and DgbnD1_ER-DbolN strains to
salts of aluminium, zinc, cobalt, copper, cadmium, nickel and
lead at various concentrations up to 100 mM. No decrease in
metal ion tolerance was observed for the bolagladin non-
producing mutant relative to parent strain and the results of
these experiments indicated that B. gladioli is much less sus-
ceptible to metal ion toxicity than B. cenocepacia. Further
experiments demonstrated that B. gladioli could readily grow
in media containing 1 mM Ni2+, Al2+ and Zn2+. Additional
work is required to establish the genetic basis for this high
degree of metal ion tolerance.
Figure 9. Conservation of the bolagladin biosynthetic gene cluster in B. gladioli. The gene cluster was extracted from six B. gladioli genome assem-
blies (BCC1622, BCC0238, BCC1665, BCC1675, BCC1781, and BCC1837, all of which are CF lung infection isolates) that highlight the diversity of
gene insertions, deletions, and substitutions flanking the cluster. B. gladioli BCC1835 and BCC1838 were included as examples of strains lacking
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Conclusion
Bacteria belonging to the Burkholderia genus are in-
creasingly being recognised as an underexplored source of
novel natural products.[34] Using a combination of carbon
source modification and inactivation of the biosynthetic
pathway for gladiolin, which is produced at high titre and
interferes with the detection of lower abundance metabolites,
we have identified bolagladins A (1) and (2) as the metabolic
product of a cryptic nonribosomal peptide biosynthetic gene
cluster in B. gladioli. Similar approaches may prove useful for
identifying the products of other cryptic Burkholderia bio-
synthetic gene clusters.
The bolagladins have very unusual structures, consisting
of a unique fatty acid residue with several polar functional
groups appended to its tail, linked via a very rare Dba residue
to a depsitetrapeptide. Identification of the bolagladin bio-
synthetic gene cluster in B. gladioli BCC0238 and BCC1622
enabled us to probe the origin of these unusual structural
features using a combination of detailed bioinformatics ana-
lysis, gene deletions and enzyme activity assays. Based on
these studies, we propose that the fatty acid residue originates
from a citryl-CoA starter unit. To our knowledge, there is no
precedent for the utilisation of citryl-CoA as a starter unit in
fatty acid or polyketide biosynthesis. We also hypothesise that
the Dba residue derives from loading of aspartate onto
a freestanding ACP. The resulting isoaspartyl thioester is
proposed to undergo decarboxylation and N-acylation, prior
to being desaturated by a flavin-dependent dehydrogenase,
resulting in an N-acyl-Dba thioester starter unit for the NRPS
that assembles the depsitetrapeptide. While loading of as-
partate/b-methyl-aspartate onto a standalone ACP, followed
by decarboxylation and N-acylation, is a well-established
mechanism for provision of b-aminoacyl starter units to type I
modular PKSs,[35] to our knowledge there is no precedent for
this mechanism being employed to provide such starter units
to NRPSs. Thus, our findings expand the scope of b-aminoacyl
starter unit biosynthetic machinery, which may prove useful in
bioengineering approaches to natural product diversification.
The bolagladin biosynthetic gene cluster is present in
approximately 45% of B. gladioli genomes, but was not found
in other Burkholderia species. This suggests the bolagladins
play an important role in the adaption of B. gladioli to its
environmental niches. Several lines of evidence indicate that
the bolagladins may function as siderophores, further chal-
lenging the assumption that B. gladioli employs siderophore-
independent mechanisms for iron acquisition.[15–16] While the
mode of ferric iron binding to the bolagladins remains to be
established, it seems likely that the two citrate-derived car-
boxy and methoxy groups in the unusual fatty acid residue,
and one or both of the side-chain hydroxyl groups in the
depsipetide are involved. Siderophores are known to play
roles in virulence and metal ion tolerance in other Burkhol-
deria species, but a Galleria mellonella infection model did
not provide evidence that the bolagladins contribute to viru-
lence in B. gladioli and bolagladin-deficient mutants did not
show reduced tolerance towards metal ions. Further studies
are therefore required to develop a better understanding of
the adaptive benefit the bolagladins confer on B. gladioli.
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Discovery and Biosynthesis of
Bolagladins: Unusual Lipodepsipeptides
from Burkholderia gladioli Clinical Isolates
Bolagladins A and B were discovered as
products of a cryptic nonribosomal pep-
tide synthetase in two Burkholderia glad-
ioli strains isolated from the lungs of
cystic fibrosis patients. These metabo-
lites contain a unique citrate-primed fatty
acid and a rare dehydro-b-alanine residue.
A combination of bioinformatics analysis
and genetic and biochemical experiments
illuminated the mechanisms for the
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